These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 39236780)
1. Methods to characterize lactate turnover in aging and Alzheimer's disease; The LEAN study. Kemna RE; Kueck PJ; Blankenship AE; John CS; Johnson CN; Green ZD; Chamberlain T; Thyfault JP; Mahnken JD; Miller BF; Morris JK Contemp Clin Trials; 2024 Sep; 146():107682. PubMed ID: 39236780 [TBL] [Abstract][Full Text] [Related]
2. Acute exercise alters brain glucose metabolism in aging and Alzheimer's disease. Green ZD; John CS; Kueck PJ; Blankenship AE; Kemna RE; Johnson CN; Yoksh LE; Best SR; Donald JS; Mahnken JD; Burns JM; Vidoni ED; Morris JK J Physiol; 2024 Sep; ():. PubMed ID: 39258961 [TBL] [Abstract][Full Text] [Related]
3. Rationale and methods to characterize the acute exercise response in aging and Alzheimer's Disease: the AEROBIC pilot study. Green ZD; John CS; Kueck PJ; Burns JM; Perry M; Donald J; Mahnken JD; Honea RA; Vidoni ED; Morris JK Contemp Clin Trials; 2021 Aug; 107():106457. PubMed ID: 34051350 [TBL] [Abstract][Full Text] [Related]
4. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Oh H; Madison C; Baker S; Rabinovici G; Jagust W Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008 [TBL] [Abstract][Full Text] [Related]
5. The multi-domain exercise intervention for memory and brain function in late middle-aged and older adults at risk for Alzheimer's disease: A protocol for Western-Eastern Brain Fitness Integration Training trial. Chang YK; Erickson KI; Aghjayan SL; Chen FT; Li RH; Shih JR; Chang SH; Huang CM; Chu CH Front Aging Neurosci; 2022; 14():929789. PubMed ID: 36062144 [TBL] [Abstract][Full Text] [Related]
7. Biomarker Responses to Acute Exercise and Relationship with Brain Blood Flow. Morris JK; Kueck PJ; Kemna RE; Green ZD; John CS; Winter M; Billinger SA; Vidoni ED J Alzheimers Dis; 2024; 97(1):283-292. PubMed ID: 38108352 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial. Yu F; Lin FV; Salisbury DL; Shah KN; Chow L; Vock D; Nelson NW; Porsteinsson AP; Jack C Trials; 2018 Dec; 19(1):700. PubMed ID: 30577848 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. The Independent Walking for Brain Health Intervention for Older Adults: Protocol for a Pilot Randomized Controlled Trial. Hays Weeks CC; Moore AA; Allison M; Patrick K; Bondi MW; Nebeker C; Liu TT; Wing D; Higgins M; Hartman SJ; Rissman RA; Zlatar ZZ JMIR Res Protoc; 2023 Feb; 12():e42980. PubMed ID: 36535765 [TBL] [Abstract][Full Text] [Related]
11. Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial. Vidoni ED; Morris JK; Watts A; Perry M; Clutton J; Van Sciver A; Kamat AS; Mahnken J; Hunt SL; Townley R; Honea R; Shaw AR; Johnson DK; Vacek J; Burns JM PLoS One; 2021; 16(1):e0244893. PubMed ID: 33444359 [TBL] [Abstract][Full Text] [Related]
12. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900 [TBL] [Abstract][Full Text] [Related]
14. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603 [TBL] [Abstract][Full Text] [Related]
15. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938 [TBL] [Abstract][Full Text] [Related]
16. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024 [TBL] [Abstract][Full Text] [Related]
17. "Brain-specific" nutrients: a memory cure? McDaniel MA; Maier SF; Einstein GO Nutrition; 2003; 19(11-12):957-75. PubMed ID: 14624946 [TBL] [Abstract][Full Text] [Related]
18. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600 [TBL] [Abstract][Full Text] [Related]
19. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602 [TBL] [Abstract][Full Text] [Related]
20. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease. Liu CS; Herrmann N; Song BX; Ba J; Gallagher D; Oh PI; Marzolini S; Rajji TK; Charles J; Papneja P; Rapoport MJ; Andreazza AC; Vieira D; Kiss A; Lanctôt KL BMC Geriatr; 2021 Dec; 21(1):677. PubMed ID: 34863115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]